British Journal of Cancer - Table of Contents alert Volume 115 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 115, Issue 2 (145-272) Published online 12 July 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you seen the British Journal of Cancer Minireviews feature? BJC regularly invites minireviews on topics of current interest from international authorities. Recently published minireviews include:  Hallmarks of cancer stem cell metabolism   Context-dependent effects of cellular senescence in cancer development Oncogenic KRAS signalling in pancreatic cancer View the full top 10 list on the BJC website  Minireview Top Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies Shivshankari Rajkumar and Ian R Watson Br J Cancer 2016 115: 145-155; advance online publication, June 23, 2016; 10.1038/bjc.2016.195 Abstract | Full Text Clinical Studies Top The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer Hester C van Wyk, James H Park, Joanne Edwards, Paul G Horgan, Donald C McMillan and James J Going Br J Cancer 2016 115: 156-163; advance online publication, June 14, 2016; 10.1038/bjc.2016.173 Abstract | Full Text Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer Yongjun Cha, Kyung-Ju Kim, Sae-Won Han, Ye Young Rhee, Jeong Mo Bae, Xianyu Wen, Nam-Yun Cho, Dae-Won Lee, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Seock-Ah Im, Yung-Jue Bang, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang and Tae-You Kim Br J Cancer 2016 115: 164-171; advance online publication, June 16, 2016; 10.1038/bjc.2016.176 Abstract | Full Text Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1 S Cox, C Powell, B Carter, C Hurt, Somnath Mukherjee and Thomas David Lewis Crosby Br J Cancer 2016 115: 172-177; advance online publication, June 21, 2016; 10.1038/bjc.2016.129 Abstract | Full Text Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation Jo S Stenehjem, Knut B Smeland, Klaus Murbraech, Harald Holte, Stein Kvaløy, Lene Thorsen, Ingerid Arbo, Lee W Jones, Svend Aakhus, May Brit Lund and Cecilie E Kiserud Br J Cancer 2016 115: 178-187; advance online publication, June 28, 2016; 10.1038/bjc.2016.180 Abstract | Full Text Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer E Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, Robert El-Maraghi, Wen Wee Ma, Michele Reni, Marion Harris, Robert Whorf, Helen Liu, Jack Shiansong Li, Victoria Manax, Alfredo Romano, Brian Lu and David Goldstein Br J Cancer 2016 115: 188-194; advance online publication, June 28, 2016; 10.1038/bjc.2016.185 Abstract | Full Text Translational Therapeutics Top Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy Yoichiro Yamamoto, Chetan P Offord, Go Kimura, Shigehiko Kuribayashi, Hayato Takeda, Shinichi Tsuchiya, Hisashi Shimojo, Hiroyuki Kanno, Ivana Bozic, Martin A Nowak, Željko Bajzer and David Dingli Br J Cancer 2016 115: 195-202; 10.1038/bjc.2016.171 Abstract | Full Text Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways Hao Zhang, Huanjie Shao, Vita M Golubovskaya, Hongbin Chen, William Cance, Alex A Adjei and Grace K Dy Br J Cancer 2016 115: 203-211; advance online publication, June 23, 2016; 10.1038/bjc.2016.190 Abstract | Full Text Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival Justyna A Kucia-Tran, Valtteri Tulkki, Stephen Smith, Cinzia G Scarpini, Katherine Hughes, Angela M Araujo, Ka Yin Matthew Yan, Jan Botthof, Eduardo Pérez-Gómez, Miguel Quintanilla, Kate Cuschieri, Maria M Caffarel and Nicholas Coleman Br J Cancer 2016 115: 212-222; advance online publication, June 28, 2016; 10.1038/bjc.2016.199 Abstract | Full Text Molecular Diagnostics Top A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma Michelle Chin I Lo, Anna Paterson, Jane Maraka, Richard Clark, Joseph Goodwill, Jenny Nobes, Jennifer Garioch, Marc Moncrieff, Ed Rytina and Laszlo Igali Br J Cancer 2016 115: 223-227; advance online publication, June 23, 2016; 10.1038/bjc.2016.106 Abstract | Full Text Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab Cong Zhou, Andrew Clamp, Alison Backen, Carlo Berzuini, Andrew Renehan, Rosamonde E Banks, Richard Kaplan, Stefan J Scherer, Gunnar B Kristensen, Eric Pujade-Lauraine, Caroline Dive and Gordon C Jayson Br J Cancer 2016 115: 228-235; advance online publication, June 28, 2016; 10.1038/bjc.2016.194 Abstract | Full Text KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach William JF Green, Graham Ball, Geoffrey Hulman, Catherine Johnson, Gerry Van Schalwyk, Hari L Ratan, Daniel Soria, Jonathan M Garibaldi, Richard Parkinson, Joshua Hulman, Robert Rees and Desmond G Powe Br J Cancer 2016 115: 236-242; advance online publication, June 23, 2016; 10.1038/bjc.2016.169 Abstract | Full Text WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway Ruixiang Tang, Yingying Lei, Bingshuang Hu, Jie Yang, Shun Fang, Qiongyao Wang, Man Li and Linlang Guo Br J Cancer 2016 115: 243-251; advance online publication, June 23, 2016; 10.1038/bjc.2016.186 Abstract | Full Text Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer Vishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, Mariano Severgnini, Jun Zhou, Nicole G Chau, Guilherme Rabinowits, Jochen H Lorch, Peter S Hammerman, F Stephen Hodi, Robert I Haddad, Roy B Tishler and Jonathan D Schoenfeld Br J Cancer 2016 115: 252-260; advance online publication, July 5, 2016; 10.1038/bjc.2016.166 Abstract | Full Text Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme? Elizabeth Walsh, Colin J Rees, Michael Gill, Clare E Parker, Roisin Bevan, Sarah L Perry, Yvonne Bury, Sarah Mills, D Michael Bradburn, Michael Bramble and Mark A Hull Br J Cancer 2016 115: 261-265; advance online publication, May 24, 2016; 10.1038/bjc.2016.159 Abstract | Full Text Genetics and Genomics Top Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer David Jarvis, Jonathan S Mitchell, Philip J Law, Kimmo Palin, Sari Tuupanen, Alexandra Gylfe, Ulrika A Hänninen, Tatiana Cajuso, Tomas Tanskanen, Johanna Kondelin, Eevi Kaasinen, Antti-Pekka Sarin, Jaakko Kaprio, Johan G Eriksson, Harri Rissanen, Paul Knekt, Eero Pukkala, Pekka Jousilahti, Veikko Salomaa, Samuli Ripatti, Aarno Palotie, Heikki Järvinen, Laura Renkonen-Sinisalo, Anna Lepistö, Jan Böhm, Jukka-Pekka Meklin, Nada A Al-Tassan, Claire Palles, Lynn Martin, Ella Barclay, Susan M Farrington, Maria N Timofeeva, Brian F Meyer, Salma M Wakil, Harry Campbell, Christopher G Smith, Shelley Idziaszczyk, Timothy S Maughan, Richard Kaplan, Rachel Kerr, David Kerr, Daniel D Buchanan, Aung K Win, John L Hopper, Mark A Jenkins, Noralane M Lindor, Polly A Newcomb, Steve Gallinger, David Conti, Fred Schumacher, Graham Casey, Jussi Taipale, Lauri A Aaltonen, Jeremy P Cheadle, Malcolm G Dunlop, Ian P Tomlinson and Richard S Houlston Br J Cancer 2016 115: 266-272; advance online publication, June 23, 2016; 10.1038/bjc.2016.188 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.